Skip to main content
Account

Table 1 Summary of study characteristics

From: Effect of high-flow nasal oxygen therapy on perioperative hypoxemia in children: a systematic review and meta-analysis

Perioperative phase

Author (year)

Country

Type of study

Total no. of patients

No. of patients (Control)

No. of patients (HFNC)

Anesthesia induction

Riva (2018)

Switzerland

RCT: induction general-anesthesia

38

20

20

Riva (2018)

Switzerland

RCT: induction general-anesthesia

40

20

20

Procedure sedation

Teppei (2020)

Japan

RCT: procedure, dental intravenous sedation

30

15

15

Sharluyan (2021)

Spain

RCT: procedure, flexible bronchoscopy sedation

104

53

51

Duan (2021)

China

RCT: procedure, repair Congenital Heart Disease sedation

195

99

96

Lei (2023)

China

RCT: surgery, JORRP tubeless airway surgery

28

14

14

Ran (2022)

China

RCT: surgery, dental procedures or oral surgeries

120

60

60

After extubation

Lee (2021)

Koreo

RCT: PACU oxygen

78

38

40

Wei (2022)

China

RCT: PACU oxygen

40

20

20

Oxygenation method (Control)

Oxygenation method (HFNC)

Age in years

Male n (%)

Weight

Desaturation definition

Nasal cannula, 0.2 L/kg/min, FiO2 1.0

Device: Optiflow, 2 L/kg/min, FiO2 1.0

3.5 ± 1.6

29 (72.5%)

15.1 ± 3.0

95%

Nasal cannula, 0.2 L/kg/min, FiO2 1.0

Device: Optiflow, 2 L/kg/min, FiO2 0.3

3.7 ± 1.5

30 (75%)

15.2 ± 2.7

95%

Nasal prongs, 5 L/min, FiO2 = 0.4

Device: Airvo 2, 2 L/kg/min up to a maximum of 30 L/minute, FiO2 1.0

6 ± 2.3

20 (66.67%)

21.6 ± 6.9

95%

1 month–2 years: 1L/min

2–16 y: 2 L/min

Device: Airvo2 or MR730,4,5,8,10,15, and 20 L/min, for weight ranges: 4–8 kg, 8–10 kg, 11–15 kg, 15–30 kg, 30–50 kg, and > 50 kg, FIO2 1

4.3 ± 5.4

58 (55.77%)

17.9 ± 14.6

80%

Simple mask, 5 L/min, FiO2: 0.35 to 0.5

Device: Optiflow, 5–15 kg, 2 L/kg/min; 15–30 kg, 35 L/min; 30–50 kg, 40 L/min; > 50 kg, 50 L/min, FiO2 0.4

3.3 ± 2.1

92 (47.18%)

15.4 ± 8.1

90%

Remaining apneic without oxygen supplementation

Device: Optiflow, 5–15 kg, 2 L/kg/min; 15–30 kg, 35 L/min; 30–0 kg, 40 L/min; > 50 kg, 50 L/min, FiO2 1.0

5.4 ± 2.8

14 (50%)

N

90%

LMA, maintaining spontaneous breathing

Device:OH-70C,2 L/kg/min, FiO2 1.0

4.7 ± 1.4

64 (53.33%)

17.7 ± 4.2

95%

Nasal cannula, 1–2 L/min

Device: Optiflow, 2 L/kg/min, FiO2 0.6

10.4 ± 6.0

56 (71.79%)

9.0 ± 2.5

95%

Air

Device: Optiflow, 25 L/min, FiO2 1.0

4.3 ± 0.8

21 (52.5%)

20.6 ± 4.6

92%

  1. Control = conventional oxygenation using simple facemask or low-flow nasal cannula or LMA or no additional respiratory support
  2. Abbreviations: HFNC high-flow nasal cannula, RCT randomized controlled trial, FiO2 fraction of inspired oxygen, PACU Post-anesthesia Care Unit, LMA laryngeal mask airway, JORRP Juvenile onset recurrent respiratory papillomatos